Showing results (71-80 of 109) with videos related to
Sort By:
Pageof 11
Osteoarthritis and Cartilage Open|December 7, 2022
The associations of psychological symptoms and cognitive patterns with pain and pain sensitization in people with hand osteoarthritisElisabeth Mulrooney, Tuhina Neogi, Hanne Dagfinrud, et al.Annals of the Rheumatic Diseases|October 7, 2016
Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD studyBrigitte Michelsen, Eirik Klami Kristianslund, Hilde Berner Hammer, et al.Annals of the Rheumatic Diseases|June 24, 2018
Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomesNina Paulshus Sundlisæter, Anna-Birgitte Aga, Inge Christoffer Olsen, et al.BMJ Open|September 27, 2017
A hospital-based observational cohort study exploring pain and biomarkers in patients with hand osteoarthritis in Norway: The Nor-Hand protocolMarthe Gløersen, Elisabeth Mulrooney, Alexander Mathiessen, et al.RMD Open|February 6, 2021
Value of MRI and ultrasound for prediction of therapeutic response and erosive progression in patients with early rheumatoid arthritis managed by an aggressive treat-to-target strategyUlf Sundin, Nina Paulshus Sundlisater, Anna-Birgitte Aga, et al.Annals of the Rheumatic Diseases|July 23, 2017
Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD studyBrigitte Michelsen, Eirik Klami Kristianslund, Joseph Sexton, et al.Annals of the Rheumatic Diseases|August 14, 2021
Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatmentKaren Holten, Nina Paulshus Sundlisater, Siri Lillegraven, et al.Rheumatology (Oxford, England)|February 9, 2022
Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaborationBénédicte Delcoigne, Sella Aarrestad Provan, Hilde Berner Hammer, et al.RMD Open|May 14, 2016
Exploring a new ultrasound score as a clinical predictive tool in patients with rheumatoid arthritis starting abatacept: results from the APPRAISE studyMaria-Antonietta D'Agostino, Maarten Boers, Richard J Wakefield, et al.RMD Open|December 20, 2018
Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trialLena Bugge Nordberg, Siri Lillegraven, Anna-Birgitte Aga, et al.Pageof 11